|
Real-time Estimate
Cboe Europe
05:33:25 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 119.70 GBX | -0.75% |
|
-0.50% | -4.16% |
| 07-13 | PureTech Health announces first patient dosing in Celea phase 3 trial | AN |
| 07-13 | PureTech Health: Celea Therapeutics Kicks Off Late-stage Trial for Idiopathic Pulmonary Fibrosis Drug | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.75% | -0.50% | +0.84% | -3.70% | -4.16% | +1.53% | -40.10% | -65.17% | -23.21% | 398M | |
| -0.46% | -3.46% | -3.76% | +14.00% | +3.72% | -2.17% | +15.30% | -27.52% | +200.70% | 48.41B | |
| -0.40% | +2.16% | +2.37% | +40.74% | +163.68% | +418.57% | +554.47% | +582.33% | - | 45.01B | |
| -1.42% | +2.52% | +12.18% | +45.96% | +18.79% | +42.67% | +22.27% | +1.26% | +244.66% | 44.07B | |
| -1.22% | -0.37% | +2.87% | +32.64% | +17.92% | +4.82% | +84.42% | +3.36% | +1,076.55% | 40.73B | |
| -0.96% | -1.38% | -6.52% | +8.69% | +8.07% | +15.75% | +45.91% | -18.93% | +139.49% | 33.21B | |
| -0.21% | +2.86% | +5.93% | +28.56% | - | - | - | - | - | 17.77B | |
| -0.35% | -0.45% | +0.10% | +30.17% | +5.28% | +21.42% | +117.63% | +205.09% | +1,911.19% | 16.5B | |
| -0.56% | -0.67% | +1.48% | +9.56% | +13.91% | +11.20% | +31.19% | -43.50% | +88.49% | 14.45B | |
| -1.65% | +0.09% | +7.85% | +59.09% | +44.63% | +75.93% | +41.15% | -35.77% | +251.49% | 13.77B | |
| +0.78% | -0.08% | +0.21% | +10.30% | -9.53% | -5.74% | -36.13% | -36.97% | +115.27% | 12.72B | |
| -0.06% | +2.49% | +24.15% | +39.18% | +9.43% | -18.84% | - | - | - | 11.66B | |
| -0.03% | +0.17% | +0.19% | +39.32% | +23.16% | +33.12% | -2.10% | -43.66% | +163.62% | 11.36B | |
| +0.17% | -4.71% | -8.88% | +78.85% | +45.13% | +31.82% | +52.14% | -51.53% | - | 10.37B | |
| -0.94% | +0.43% | -2.48% | +38.51% | +19.36% | +650.93% | +1,528.75% | +3.96% | - | 9.82B | |
| +0.20% | -0.30% | -11.66% | +10.10% | -18.48% | +30.35% | +477.35% | +182.85% | +2,403.83% | 9.93B | |
| +0.09% | -1.20% | +9.18% | +58.36% | +50.87% | +169.80% | +518.82% | +85.63% | - | 9.76B | |
| -0.07% | -3.76% | +2.71% | -22.01% | -26.57% | -5.13% | +43.86% | +54.70% | +92.93% | 9.65B | |
| -2.07% | -1.37% | -0.10% | +49.64% | +66.84% | +140.74% | +676.76% | +199.65% | +1,053.76% | 9.43B | |
| -0.89% | +0.42% | +2.77% | +18.51% | -8.17% | -13.15% | -7.49% | -31.06% | +39.21% | 8.99B | |
| Average | -0.54% | -0.40% | +1.97% | +29.32% | +22.31% | +84.40% | +229.12% | +53.60% | +554.14% | 18.9B | |
| Weighted average by Cap. | -0.67% | -0.21% | +2.10% | +30.25% | +32.75% | +91.11% | +189.91% | +86.07% | +524.92% |
- Stock Market
- Stocks
- PRTC Stock
- Sector PureTech Health plc
Select your edition
All financial news and data tailored to specific country editions
